Institutional Perspectives in Neurology: Multiple Sclerosis
NeurologyLive® State of the Science Summits are short meetings designed to educate neurologists and advanced practice providers on the clinical benefits associated with the new science driving new thinking, featuring renowned faculty who focus on the most relevant topics to ultimately improve patient care.
Cutting Edge Care in Multiple Sclerosis: Advances in S1P Therapy
July 28th 2021Jessica L. Stulc, MD, MPH, offered an in-depth review of the latest approved therapies in the sphingosine phosphate 1 targeting class of oral medications for MS including ozanimod (Zeposia; BMS) and ponesimod (Ponvory; Janssen).
Identifying Atypical Forms, Presentations of Demyelinating Disease: Oliver Tobin, MBBCh, BAO, PhD
July 20th 2021The associate professor of neurology at Mayo Clinic Rochester discusses the importance of alternative diagnoses and rarer presentations of MS, in order to avoid misdiagnoses and inappropriate treatment for patients.
Mayo Clinic: Institutional Perspectives in Neurology, Chaired by Brian G. Weinshenker, MD
July 16th 2021Chaired by Brian G. Weinshenker, MD, the presentations also feature Mayo Clinic experts W. Oliver Tobin, MBBCh, BAO, PhD; Jessica Stulc, MD, MPH; and Orhun H. Kantarci, MD. [WATCH TIME: 1 hour, 30 minutes]
